Related by context. Frequent words. (Click for all words.) 71 XL# XL# XL# XL# 70 Initiates Phase II 69 Medarex logo 68 Completes Patient Enrollment 68 Panzem R 67 oncolytic virus therapies 67 refractory chronic lymphocytic 67 Inc. Nasdaq IMGN 67 Meets Primary Endpoint 67 Receives Orphan Drug Designation 67 2 methoxyestradiol 66 ALN PCS 66 TRAIL receptor antibodies 66 R sorafenib tablets 66 YOUR LOCAL ANIMAL SHELTER 66 Belimumab 66 ALN TTR 65 products Oncaspar 65 Presents Positive 65 Sapacitabine 65 Kuvan R 65 Initiate Phase 65 www.syntapharma.com 64 sorafenib tablets 64 immuno inflammatory diseases 64 Nasdaq OSIP 64 ® bortezomib 64 BY STEPHANIE A. WILKEN 64 JAK inhibitor 64 Entereg R 64 Advancing Drugs 64 elotuzumab 64 FDA Accepts 64 Copegus R 64 Inc Therapeutic Competitors 64 multi kinase inhibitor 64 TELINTRA 63 Bafetinib 63 PRT# 63 www.BMRN.com 63 CEQ# 63 Completes Enrollment 63 developing Zerenex TM 63 REGN# 63 topical non steroidal 63 AEG# 63 Onalta 63 BY WILLIAM ROLLER 63 opioid induced bowel dysfunction 63 Inhalation Solution 63 Methylnaltrexone 63 Idera Pharmaceuticals 63 orderonlineviagra 63 Drug Candidate 63 TLR9 agonists 63 HMG CoA reductase inhibitors 63 KNS # 63 gastrointestinal mucositis 63 FDA Orphan Drug 63 Cloud Headed Next 63 NASDAQ LGND 63 Prestara 63 Inc. NASDAQ TRGT 63 ASG 5ME 62 Romidepsin 62 Fibrillex TM 62 Exelixis logo 62 BY ROB WEILER 62 Vaccinex 62 VEGFR2 inhibitor 62 Saxagliptin 62 Ore Pharmaceuticals 62 VIVITROL ® 62 Plicera 62 RhuDex ® 62 pediatric Crohn disease 62 Panzem R NCD 62 Idera Pharmaceuticals develops 62 Phase Ib study 62 Pimavanserin 62 Coadministration 62 NASDAQ ABII 62 Takeda Kyowa Hakko Kirin 62 proteasome inhibitor 62 Taiho Pharmaceutical 62 Patient Enrollment 62 MKC# 62 Anti Tumor 62 addressing idiopathic pulmonary 62 Paris EURONEXT SAN 62 Nasdaq ENMD 62 www.vivus.com 62 BY MICHAEL GELBWASSER 62 http:/www.nabi.com 62 Sunesis Pharmaceuticals 62 dacetuzumab 61 liposomal formulation 61 generation proteasome inhibitor 61 Kinase Inhibitor 61 Unit Dose Budesonide 61 Phase Ib clinical trials